Search research articles
Contact Us
Filters
Showing results (21-30 of 114) with videos related to
Page
of 12
Sort By:
Haematologica
|
August 16, 2019
Phase I/Ib study of carfilzomib and panobinostat with or without dexamethasone in patients with relapsed/refractory multiple myeloma
Elisabet E Manasanch, Jatin J Shah, Hans C Lee, et al.
American Journal of Hematology
|
September 7, 2019
A phase I/II trial of the combination of lenalidomide, thalidomide and dexamethasone in relapsed and/or refractory multiple myeloma
Hans C Lee, Jatin J Shah, Lei Feng, et al.
Hepatology International
|
December 8, 2022
Hepatitis B virus reactivation in patients with past HBV infection receiving anti-CD38 monoclonal antibodies
Chia-Yu Chiu, Krina Patel, Sheeba K Thomas, et al.
Cancer
|
March 26, 2011
Solitary plasmacytomas: outcome and prognostic factors after definitive radiation therapy
Valerie Reed, Jatin Shah, L Jeffery Medeiros, et al.
The Journal of Pain
|
July 27, 2015
Measuring Therapy-Induced Peripheral Neuropathy: Preliminary Development and Validation of the Treatment-Induced Neuropathy Assessment Scale
Tito R Mendoza, Xin Shelley Wang, Loretta A Williams, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 11, 2017
Additional-structural-chromosomal aberrations are associated with inferior clinical outcome in patients with hyperdiploid multiple myeloma: a single-institution experience
Adrian A Carballo-Zarate, L Jeffrey Medeiros, Lianghua Fang, et al.
Human Pathology
|
October 16, 2022
Lymphoplasmacytic lymphoma with IgG or IgA paraprotein: a study of 29 cases including cases that can mimic plasma cell neoplasms
Lianqun Qiu, Okechukwu V Nwogbo, L Jeffrey Medeiros, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 1, 2017
Clinical implications of cytogenetic heterogeneity in multiple myeloma patients with TP53 deletion
Suyang Hao, Pei Lin, L Jeffrey Medeiros, et al.
Cancer Chemotherapy and Pharmacology
|
October 24, 2013
Evaluation of the QTc prolongation potential of a monoclonal antibody, siltuximab, in patients with monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, or low-volume multiple myeloma
Sheeba K Thomas, Alexander Suvorov, Lucien Noens, et al.
Blood Cancer Journal
|
October 3, 2019
A phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma
Hans C Lee, Jatin J Shah, Lei Feng, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 114) with videos related to
Sort By:
Page
of 12
Haematologica
|
August 16, 2019
Phase I/Ib study of carfilzomib and panobinostat with or without dexamethasone in patients with relapsed/refractory multiple myeloma
Elisabet E Manasanch, Jatin J Shah, Hans C Lee, et al.
American Journal of Hematology
|
September 7, 2019
A phase I/II trial of the combination of lenalidomide, thalidomide and dexamethasone in relapsed and/or refractory multiple myeloma
Hans C Lee, Jatin J Shah, Lei Feng, et al.
Hepatology International
|
December 8, 2022
Hepatitis B virus reactivation in patients with past HBV infection receiving anti-CD38 monoclonal antibodies
Chia-Yu Chiu, Krina Patel, Sheeba K Thomas, et al.
Cancer
|
March 26, 2011
Solitary plasmacytomas: outcome and prognostic factors after definitive radiation therapy
Valerie Reed, Jatin Shah, L Jeffery Medeiros, et al.
The Journal of Pain
|
July 27, 2015
Measuring Therapy-Induced Peripheral Neuropathy: Preliminary Development and Validation of the Treatment-Induced Neuropathy Assessment Scale
Tito R Mendoza, Xin Shelley Wang, Loretta A Williams, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 11, 2017
Additional-structural-chromosomal aberrations are associated with inferior clinical outcome in patients with hyperdiploid multiple myeloma: a single-institution experience
Adrian A Carballo-Zarate, L Jeffrey Medeiros, Lianghua Fang, et al.
Human Pathology
|
October 16, 2022
Lymphoplasmacytic lymphoma with IgG or IgA paraprotein: a study of 29 cases including cases that can mimic plasma cell neoplasms
Lianqun Qiu, Okechukwu V Nwogbo, L Jeffrey Medeiros, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 1, 2017
Clinical implications of cytogenetic heterogeneity in multiple myeloma patients with TP53 deletion
Suyang Hao, Pei Lin, L Jeffrey Medeiros, et al.
Cancer Chemotherapy and Pharmacology
|
October 24, 2013
Evaluation of the QTc prolongation potential of a monoclonal antibody, siltuximab, in patients with monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, or low-volume multiple myeloma
Sheeba K Thomas, Alexander Suvorov, Lucien Noens, et al.
Blood Cancer Journal
|
October 3, 2019
A phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma
Hans C Lee, Jatin J Shah, Lei Feng, et al.
Page
of 12